Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Xbiome Gut Microbial Capsule XBI-302 in Healthy Volunteers

NCT05352269 is registered in ClinicalTrials.gov with Shenzhen Xbiome Biotech Co., Ltd. as lead sponsor.

NCT NCT05352269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05352269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Xbiome Gut Microbial Capsule XBI-302 in Healthy Volunteers
Lead sponsor
Shenzhen Xbiome Biotech Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
April 21, 2022
Completion date
October 31, 2022
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-graft-versus-host disease